Literature DB >> 22451263

Lung function in young adults with congenital diaphragmatic hernia; a longitudinal evaluation.

Marjolein Spoel1, Monique H M van der Cammen-van Zijp, Wim C J Hop, Dick Tibboel, Johan C de Jongste, Hanneke Ijsselstijn.   

Abstract

BACKGROUND: Survival rates of patients with congenital diaphragmatic hernia (CDH) have improved to up to 80%. Little is known about long-term consequences of the disease and its treatment. We evaluated lung function and respiratory symptoms longitudinally in a previously studied cohort of CDH patients and age-matched non-CDH patients who underwent similar neonatal intensive care treatment. STUDY
DESIGN: We tested 27 young adults [mean (SD) age: 26.8 years (2.9)] with CDH and 30 non-CDH patients. Dynamic and static lung volumes, midexpiratory flows, and diffusion capacity were expressed as mean (SD) standard deviation scores. Prevalence of respiratory symptoms was evaluated with the European Community Respiratory Health Survey.
RESULTS: All data are expressed as mean (SD). FEF(25-75) in CDH patients had slightly deteriorated since childhood (CDH: -0.7 (1.4) vs. -1.6 (1.5), P < 0.001; non-CDH patients: 0.2 (1.4) vs. -0.3 (1.6), P = 0.038, ns). Diffusion capacity decreased in both groups (CDH: DL(CO) c 0.2 (1.1) vs. -1.5 (1.1), P <0.001; non-CDH: DL(CO) c 0.1 (0.4) vs. -1.1 (1.1), P < 0.001). Lung volumes were normal in both groups. The prevalence of asthma was higher than in the normal population (27.6% in patients and 30% in controls, P < 0.001).
CONCLUSIONS: Airflow obstruction and diffusion capacity deteriorated mildly from childhood into adulthood in survivors of CDH. The improved survival of patients with more severe forms of diaphragmatic hernia calls for long-term follow-up of lung function.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22451263     DOI: 10.1002/ppul.22557

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

1.  Region of interest-based versus whole-lung segmentation-based approach for MR lung perfusion quantification in 2-year-old children after congenital diaphragmatic hernia repair.

Authors:  M Weis; V Sommer; F G Zöllner; C Hagelstein; K Zahn; T Schaible; S O Schoenberg; K W Neff
Journal:  Eur Radiol       Date:  2016-04-06       Impact factor: 5.315

Review 2.  Congenital diaphragmatic hernia.

Authors:  Augusto Zani; Wendy K Chung; Jan Deprest; Matthew T Harting; Tim Jancelewicz; Shaun M Kunisaki; Neil Patel; Lina Antounians; Pramod S Puligandla; Richard Keijzer
Journal:  Nat Rev Dis Primers       Date:  2022-06-01       Impact factor: 52.329

3.  High temporal versus high spatial resolution in MR quantitative pulmonary perfusion imaging of two-year old children after congenital diaphragmatic hernia repair.

Authors:  M Weidner; F G Zöllner; C Hagelstein; K Zahn; T Schaible; S O Schoenberg; L R Schad; K W Neff
Journal:  Eur Radiol       Date:  2014-07-20       Impact factor: 5.315

4.  Lung function in school-aged congenital diaphragmatic hernia patients; a longitudinal evaluation.

Authors:  Leontien C C Toussaint-Duyster; Monique H M van der Cammen-van Zijp; Marjolein Spoel; Harm A W M Tiddens; Dick Tibboel; Rene M H Wijnen; Joost van Rosmalen; Hanneke IJsselstijn
Journal:  Pediatr Pulmonol       Date:  2019-06-13

5.  Risk factors affecting postoperative pulmonary function in congenital diaphragmatic hernia.

Authors:  Qianqian Wang; Quanhua Liu; Jingyu Zang; Jun Wang; Jie Chen
Journal:  Ann Surg Treat Res       Date:  2020-03-31       Impact factor: 1.859

Review 6.  Small Extracellular Vesicles from Human Amniotic Fluid Samples as Promising Theranostics.

Authors:  Ambra Costa; Rodolfo Quarto; Sveva Bollini
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

7.  Novel Use of a Bronchial Blocker in a Challenging Case of Congenital Diaphragmatic Hernia-A Case Report.

Authors:  Deepika Sankaran; Shinjiro Hirose; Donald Morley Null; Niroop R Ravula; Satyan Lakshminrusimha
Journal:  Children (Basel)       Date:  2021-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.